MSJCX
Price
$15.92
Change
+$0.03 (+0.19%)
Updated
Dec 20 closing price
SFCWX
Price
$69.39
Change
-$0.28 (-0.40%)
Updated
Dec 20 closing price
Ad is loading...

MSJCX vs SFCWX

Header iconMSJCX vs SFCWX Comparison
Open Charts MSJCX vs SFCWXBanner chart's image
Morgan Stanley Global Endurance C
Price$15.92
Change+$0.03 (+0.19%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World F3
Price$69.39
Change-$0.28 (-0.40%)
VolumeN/A
CapitalizationN/A
MSJCX vs SFCWX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSJCX vs. SFCWX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSJCX is a Hold and SFCWX is a Buy.

FUNDAMENTALS
Fundamentals
SFCWX has more cash in the bank: 73.6B vs. MSJCX (28.1M). MSJCX pays higher dividends than SFCWX: MSJCX (1.03) vs SFCWX (0.95). MSJCX was incepted earlier than SFCWX: MSJCX (6 years) vs SFCWX (8 years). MSJCX is a more actively managed with annual turnover of: 130.00 vs. SFCWX (29.00). MSJCX has a lower initial minimum investment than SFCWX: MSJCX (1000) vs SFCWX (1000000). MSJCX annual gain was more profitable for investors over the last year : 5.01 vs. SFCWX (4.67). MSJCX return over 5 years is better than : 25.54 vs. SFCWX (14.96).
MSJCXSFCWXMSJCX / SFCWX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years8 years-
Gain YTD5.2913.494151%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets28.1M73.6B0%
Annual Yield % from dividends1.030.95108%
Returns for 1 year5.014.67107%
Returns for 3 years-40.50-11.01368%
Returns for 5 years25.5414.96171%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMRC36.920.67
+1.85%
Digimarc Corp
DNLI21.45-0.04
-0.19%
Denali Therapeutics
AIM0.19N/A
-0.58%
AIM ImmunoTech
LYEL0.61-0.03
-4.41%
Lyell Immunopharma
XPO135.25-10.26
-7.05%
XPO